High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis
Public ClinicalTrials.gov record NCT00983983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Safety and Tolerability Study of High Fat/High Calorie Versus High Calorie Versus Optimal Nutrition in Subjects With Amyotrophic Lateral Sclerosis
Study identification
- NCT ID
- NCT00983983
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Massachusetts General Hospital
- Other
- Enrollment
- 28 participants
Conditions and interventions
Conditions
Interventions
- Jevity 1.0 Dietary Supplement
- Jevity 1.5 Dietary Supplement
- Oxepa Dietary Supplement
Dietary Supplement
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2009
- Primary completion
- Mar 31, 2013
- Completion
- Apr 30, 2013
- Last update posted
- Feb 26, 2015
2009 – 2013
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Institute/St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| University of California at Irvine | Irvine | California | 92868 | — |
| California Pacific Medical Center, University of California at San Francisco | San Francisco | California | 94120 | — |
| Sarasota Memorial Hospital | Sarasota | Florida | 34239 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | — |
| Neurology Clinical Trials Unit, Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Saint Mary's Health Care | Grand Rapids | Michigan | 49503 | — |
| Columbia Presbyterian Medical Center | New York | New York | 10032 | — |
| Carolinas Medical Center Neuromuscular/ALS-MDA Center | Charlotte | North Carolina | 28207 | — |
| Oregan Health and Science University | Portland | Oregon | 97239 | — |
| Drexel University | Philadelphia | Pennsylvania | 19107 | — |
| Methodist Neurological Institute | Houston | Texas | 77030 | — |
| University of Vermont | Burlington | Vermont | 05401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00983983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2015 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00983983 live on ClinicalTrials.gov.